Testing the feasibility of operationalizing a prospective, randomized trial with remote cardiac safety EKG monitoring during a pandemic

BACKGROUND: The coronavirus SARS-CoV-2 is highly contagious. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2. The FDA authorized emergency use of HCQ against COVID-19. HCQ may have dose-related cardiotoxicity. This clinical trial received ethical approval on May 15, 2020, operation...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Hans H., Ezekowitz, Michael D., Columbo, Michele, Khan, Oneib, Martin, Jack, Spahr, Judith, Yaron, David, Cushinotto, Lisa, Kapelusznik, Luciano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149293/
https://www.ncbi.nlm.nih.gov/pubmed/34037911
http://dx.doi.org/10.1007/s10840-021-00989-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149293/
https://www.ncbi.nlm.nih.gov/pubmed/34037911
http://dx.doi.org/10.1007/s10840-021-00989-x

Ejemplares similares